Vimarsana
Biggest News Aggregation in the World

Paul Jun News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Paul Jun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Paul Jun Today - Breaking & Trending Today

hoopla Digital Expands BingePass Offering with Filmocracy - Vimarsana News

hoopla Digital Expands BingePass Offering with Filmocracy

/PRNewswire/ -- hoopla Digital, the only all-in-one app for public libraries, today announced the launch of a first-of-its-kind BingePass with Filmocracy that...

Filmocracy Showcases Impact Filmmaking At Second Annual Filmocracy Fest - Vimarsana News

Filmocracy Showcases Impact Filmmaking At Second Annual Filmocracy Fest

Los Angeles, CA (PRWEB) December 07, 2021 -- Filmocracy, the world’s premiere digital screening, distribution, and experience platform, has taken a strong

Source: prweb.com
Liquid Media Announced as Presenting Sponsor for Filmocracy Fest 2021 - Vimarsana News

Liquid Media Announced as Presenting Sponsor for Filmocracy Fest 2021

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
监管"治乱象"互联网保险股应声下跌 众安、慧择、水滴保费收入却大幅增长_保险_金融频道首页_财经网 - Vimarsana News

监管"治乱象"互联网保险股应声下跌 众安、慧择、水滴保费收入却大幅增长_保险_金融频道首页_财经网

监管“治乱象”互联网保险股应声下跌 众安、慧择、水滴保费收入却大幅增长

投资界24h|上市两天,滴滴市值涨至5000亿;文娱这么惨了,还有人在投;VC还不赶紧抢东北麻辣烫_原创_投资界 - Vimarsana News

投资界24h|上市两天,滴滴市值涨至5000亿;文娱这么惨了,还有人在投;VC还不赶紧抢东北麻辣烫_原创_投资界

美赛生物是国内首家专注于肿瘤免疫微环境中巨噬细胞新靶点药物开发的新兴生物技术企业。肿瘤免疫药物是目前治疗肿瘤的最重要手段,但现有的以T细胞为主的治疗手段均存在明显的局限。而靶向巨噬细胞的药物有望弥补现有肿瘤免疫药物和治疗手段的不足。本轮融资由凯风创投领投,丹麓资本跟投,所募集的资金将主要用于现有产品管线的研发和高端人才引进。阅读全文 医疗级生物传感器企业刷新智能获数千万元融资,力合科创集团领投 投资...